|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01789 AK MEDICAL
Nominal 
5.015 +0.065 (+1.313%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 764,725 | 10.155% | 1,482,439 | 1,346,377 | 1,093,862 | 1,052,047 |
| Cost of Sales | (277,284) | -2.328% | (585,044) | (538,184) | (419,376) | (415,612) |
| Gross Profit | 487,441 | 18.791% | 897,395 | 808,193 | 674,486 | 636,435 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | (18,360) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 229,718 | 23.060% | 394,979 | 319,822 | 231,117 | 240,290 | |
| Taxation | (33,001) | 26.635% | (55,885) | (45,896) | (49,013) | (35,518) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 196,717 | 22.480% | 339,094 | 273,926 | 182,104 | 204,772 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (9,525) | -51.046% | (21,099) | (19,041) | (19,634) | (20,307) |
| Depreciation & Amortisation | -- | -- | 106,880 | 96,334 | 90,939 | 80,401 |
| Directors' Emoluments | -- | -- | -- | 5,279 | 4,580 | 4,307 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | 17.680 | 22.863% | 30.400 | 24.600 | 16.000 | 18.000 |
| DPS (cts) | 0.000 | -- | 10.426 | 6.645 | 4.082 | 5.226 |
| Dividend Payout Ratio (%) | -- | -- | 34.296% | 27.013% | 25.510% | 29.036% |
| Cash flow per share ($) | -- | -- | 0.354 | 0.404 | 0.030 | 0.219 |
| NBV per share ($) | 2.521 | -- | 2.592 | 2.350 | 2.132 | 2.011 |
| Remarks: | Real time quote last updated: 04/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 196,717 |
| %Change | 22.480% |
| EPS / (LPS) | RMB 0.177 |
| NBV Per Share (¥) | RMB 2.521 |